EMCDDA publications: archives


Drugs and the darknet

28.11.2017 - The EMCDDA and Europol present the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond.


Drug testing in schools

22.11.2017 - This EMCDDA paper (17 p.) evaluates the effectiveness of random testing in schools, based on studies conducted students aged 13 to 19 years, in the United States.


Furanylfentanyl under control across the EU

15.11.2017 - the EU has decided to subject the new synthetic opioid to control measures. Member States will have one year to introduce them into national legislation.

EMCDDA-Europol Joint Report on carfentanyl

13.11.2017 - See the joint report published by the 2 organizations in accordance with Article 5 of the EU Council Decision 2005/387/JHA.












Drugs in Europe

2017 EMCDDA European Drug Report

miniEDR2017EN.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

  Country drug reports 2017

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.